Articles related to VISION/OCULAR HEALTH

The FDA classified a voluntary nationwide recall involving nearly 12 million cartons of Rohto Cooling Eye Drops after a lack of assurance of sterility was identified. The action was designated a Class II recall, indicating medically reversible risks or a remote probability of serious harm.

An ophthalmologist-inventor described automated slit-lamp imaging as a way to standardize anterior-segment documentation. The discussion emphasized workflow, ergonomics, teleophthalmology, and future AI training needs.

University of Oklahoma researchers identified a photoreceptor lysosomal recycling pathway regulated by PIKfyve. Mouse-model disruption produced photoreceptor degeneration and RPE changes resembling macular degeneration biology.

AI-enabled retinal imaging platforms are being deployed across healthcare settings to identify ocular and systemic disease signals, though the role of these technologies continues to evolve alongside regulatory approvals and clinical validation.

TFOS DEWS III proposes a driver-based approach to dry eye disease, emphasizing standardized diagnosis, disease subtyping, and layered treatment strategies matched to underlying mechanisms rather than rigid severity-based escalation.

The FDA classified the nationwide recall of more than 2.5 million bottles of Lupin’s prednisolone acetate ophthalmic suspension as a Class II recall after reports of a foreign substance in affected products.